阿扎胞苷在患者来源的滤泡辅助性T细胞淋巴瘤异种移植模型中诱导p53介导的凋亡
研究将15例滤泡辅助性T细胞淋巴瘤(TFHL)植入免疫缺陷小鼠,成功建立9例患者来源异种移植模型(PDX)。模型保留TET2突变及多数TFHL特异性突变,肿瘤微环境随传代逐渐消失。阿扎胞苷处理可重现患者敏感性,敏感模型中全局DNA低甲基化伴基因表达上调,提示p53通路介导的细胞毒性。
要点
- 成功建立9例TFHL-PDX模型,保留TET2突变及多数TFHL特异性突变。
- 肿瘤微环境在第一代可检测到,后续传代中逐渐消失。
- 阿扎胞苷在敏感PDX中引起全局DNA低甲基化并上调基因表达,提示p53介导凋亡。
核心结论
- TFHL-PDX模型重现了TFHL特征并对阿扎胞苷表现出敏感性,揭示了阿扎胞苷通过DNA低甲基化激活p53介导的凋亡机制。
研究设计与样本
- 将15例TFHL植入免疫缺陷小鼠,成功生成9例患者来源异种移植模型(TFHL-PDXs)。
- 对6例TFHL-PDX模型进行阿扎胞苷处理,分析DNA甲基化与基因表达差异。
主要发现
- 15例TFHL植入后生成9例PDX;肿瘤微环境在第一代可检测到,后续传代中逐渐消失。
- TET2突变在所有病例中持续存在,多数病例观察到TFHL特异性突变。
- 阿扎胞苷处理完全重现了患者敏感性;药物敏感模型中发生全局DNA低甲基化,耐药模型未发生。
- DNA低甲基化与全局基因表达上调相关,包括多种癌症相关通路,提示p53通路介导的细胞毒性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Follicular helper T-cell lymphoma (TFHL) is the most common non-cutaneous T-cell lymphoma in the Western world and is associated with a poor prognosis. Neoplastic cells rely heavily on the tumor microenvironment, demonstrated by the absence of TFHL-derived cell lines, which hinders therapeutic progress. To overcome this limitation, we developed and characterized patient-derived xenograft TFHL (TFHL-PDXs). Fifteen TFHLs were implanted into immunodeficient mice, generating nine PDXs. The tumor microenvironment was detected in the first passage but progressively disappeared in subsequent passages. TET2 mutations persisted in all cases and TFHL-specific mutations were observed in most. The models were treated with azacitidine and patient sensitivity was fully recapitulated. To elucidate the mechanism of action of azacitidine, we analyzed the differences in DNA methylation and gene expression in six TFHL-PDX models. Global DNA hypomethylation occurred in azacitidine-treated cells in drug-sensitive models but not in the resistant ones. DNA hypomethylation was associated with global upregulation of gene expression, including that of various cancer-related pathways, suggestive of p53-pathway-mediated cytotoxicity. Overall, the PDXs recapitulated TFHL features and exhibited sensitivity to azacitidine. They also made it possible to decipher the mechanism responsible for the effect of azacitidine, revealing the activation of p53-mediated apoptosis associated with DNA hypomethylation.
引用
- Tari Crochet G, Ari-Yuka S, Fischer A, et al. Induction of p53-mediated apoptosis by azacitidine in patient-derived xenograft follicular helper T-cell lymphoma model. Leukemia. 2025. PMID: 40394210. doi:10.1038/s41375-025-02628-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。